A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-Based Therapy
This study has been completed.
Study NCT00189358
Information provided by AGO Ovarian Cancer Study Group
First Received: September 12, 2005
No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
